A Chinese cancer precision diagnostics firm 3D Medicines recently completed a 280 million yuan (US$40 million) financing for its diagnostic business segment. This round of financing is led by China Resources Pharmaceutical Industry Investment Fund, with Luxin Venture Capital and Shandong Transportation Industry Development Fund jointly invested. Shanghai Zhangjiang Technology Venture Capital Co. , Ltd., […]
Cancer Precision Diagnosis Firm 3D Medicines Raises RMB280M comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.